• Europe is grappling with a record number of locally acquired mosquito-borne disease cases in 2025, including West Nile virus, chikungunya, and dengue.
  • The expansion of invasive mosquito species like Aedes albopictus, now established in 30 countries, is a primary driver, facilitated by climate change and record international travel.
  • Public health agencies are intensifying surveillance as the outbreaks pressure healthcare systems and spread into new northern regions previously unaffected.

Unprecedented Spread of Infections

Europe is experiencing an unprecedented surge in mosquito-borne disease outbreaks this year, with health agencies reporting record numbers of locally acquired cases driven by rising temperatures and the rapid expansion of invasive mosquito populations. As of August 2025, eight countries have reported 335 locally acquired cases of West Nile virus (WNV), resulting in 19 fatalities, with Italy bearing the brunt of the outbreak, according to data from the European Centre for Disease Prevention and Control (ECDC).

The situation is particularly acute for diseases like chikungunya, with 27 separate outbreaks recorded so far this year—a new record. In a significant shift indicating northward expansion, the first locally acquired chikungunya cases have been detected in France’s Alsace region, a latitude previously considered outside the risk zone. Dengue cases are also sharply increasing, with 304 locally acquired infections confirmed in 2024 marking the highest level on record, a trend that has continued into this year.

Climate and Travel Compound the Crisis

The primary vector for these outbreaks, the Aedes albopictus mosquito, is now established in 30 European countries, a sharp increase from just 17 in 2017. Its geographic range now covers 369 regions, up from 114 a decade ago, creating a vastly expanded pool of vulnerable populations. This biologic shift is being turbocharged by climate factors, including changing rainfall patterns and sustained warming trends, which create more hospitable breeding environments for the insects.

Compounding the biologic threat is a massive rebound in international travel, with passenger volume in Europe expected to reach 1.4 billion this year. Health officials note that an estimated 4.7% of European travelers returning from abroad are now diagnosed with an Aedes-borne disease, creating a constant risk of new introductions into local mosquito populations. “The convergence of established mosquito populations, a favorable climate, and high mobility creates a perfect storm for transmission,” said one official familiar with the matter, who spoke on condition of anonymity.

Public Health Response and Economic Strain

In response to the escalating crisis, the World Health Organization and the ECDC have intensified surveillance efforts and are providing tailored public health guidance to national governments. The WHO’s declaration of a Grade 3 global emergency for dengue in 2023 underscores the international significance of the threat. Several European countries have restarted or enhanced their seasonal surveillance programs specifically for autochthonous, or local, transmission of dengue and other arboviruses.

The rising disease burden is placing significant strain on national healthcare systems, leading to increased healthcare expenditure at a time of already tight budgets. Beyond the immediate acute care costs, diseases like chikungunya can result in chronic symptoms such as long-term joint pain, creating a lingering burden on both affected individuals and health services for years after the initial outbreak.

The outbreaks represent a fundamental shift in Europe’s disease landscape. A decade ago, these illnesses were largely confined to southern Europe, but health officials now warn that the continued northward expansion could lead to potential endemicity in new regions. Future projections are concerning; some models suggest that by the 2060s, outbreaks of dengue and chikungunya could increase fivefold compared to baseline levels from the end of the 20th century. Public health agencies are now strongly recommending that travelers seek vaccination and preventive advice before visiting affected areas, a message that was once reserved for tropical destinations far beyond Europe's borders.